检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Nikolaos Machairas Martin de Santibañes Panagiotis Dorovinis Adam Enver Frampton
机构地区:[1]nd Department of Propaedeutic Surgery,National and Kapodistrian University of Athens,Medical School,Athens,Greece [2]Department of Surgery,Division of HPB Surgery,Liver&Transplant Unit,Hospital Italiano de Buenos Aires,Argentina [3]HPB Surgical Unit,Royal Surrey County Hospital NHS Foundation Trust,Guildford,Surrey,UK [4]Surrey Cancer Research Institute,Department of Clinical and Experimental Medicine,Faculty of Health and Medical Sciences,The Leggett Building,University of Surrey,Guildford,UK
出 处:《Hepatobiliary Surgery and Nutrition》2021年第5期720-723,共4页肝胆外科与营养(英文)
摘 要:Management of patients with synchronous colorectal liver metastases(SCRLM)has transformed dramatically over the past 2 decades(1-3).A step-by-step,patient tailored approach as orchestrated by a multidisciplinary tumor board(MDT),combined with advances in surgical techniques,perioperative care and the evolution of systemic therapies have led to remarkable long-term outcomes(2,4).In particular,selected patients with resectable SCRLM undergoing surgery have been reported to enjoy 5-year survival rates as high as 76%(1).However,the optimal surgical strategy for these patients remains elusive with multiple retrospective studies presenting conflicting outcomes(4).In their up-to-date review of the literature Lillemoe and Vauthey sought to evaluate and critically appraise currently available surgical treatment strategies for patients presenting with SCRLM.
关 键 词:COLORECTAL METASTASES transformed
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.63